Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)
loading.default
item.page.files
item.page.date
item.page.authors
item.page.journal-title
item.page.journal-issn
item.page.volume-title
item.page.publisher
Genius Journals
item.page.abstract
Study of the effect of SGLT-2ingibitors on kidney function in Diabetes Mellitus Type 2 patients